Caricamento...

Identification of a New Scaffold for Hsp90 C-Terminal Inhibition

[Image: see text] Inhibition of Hsp90 C-terminal function is an advantageous therapeutic paradigm for the treatment of cancer. Currently, the majority of Hsp90 C-terminal inhibitors are derived from novobiocin, a natural product traditionally used as an antibiotic. Assisted by molecular docking stud...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Zhao, Huiping, Moroni, Elisabetta, Colombo, Giorgio, Blagg, Brian S. J.
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Chemical Society 2013
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4027776/
https://ncbi.nlm.nih.gov/pubmed/24900777
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/ml400404s
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !